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Introduction
Microtubules are a component of the mitotic spindle and are essential to the mitotic division of cells.
Tubulin is an α-β heterodimeric protein which is the main constituent of microtubules [1] . Tubulin is the target of numerous small molecule ligands that act by interfering with microtubule dynamics. These ligands can be broadly divided into two categoriesthose that inhibit the formation of the mitotic spindle and those that inhibit the disassembly of the mitotic spindle once it has formed [2] . Tubulin has three well-characterised binding sites: the taxane domain, the vinca domain and the colchicine domain and many compounds interact with tubulin at these known sites. Paclitaxel (Taxol, 1, Figure 1 ) binds to tubulin at the taxane site, the vinca alkaloids, including vinblastine (2, Figure 1 ), bind at the vinca domain and colchicine (3, Figure 1 ) binds at the colchicine domain. Paclitaxel and vinblastine are in clinical use for many types of cancer [3] . Colchicine and podophyllotoxin are colchicine-domain tubulin-binding agents that are not in clinical use due to problems of toxicity. Colchicine was the first drug known to bind to tubulin and inhibit microtubule formation as early at the 1930's [1, 4] . Colchicine is not used clinically for the treatment of cancer due to gastrointestinal side-effects. 14 To date, there is no clinically approved drug that binds to the colchicine-domain of tubulin and much work continues to be carried out in this area.
The combretastatins are a group of diaryl stilbenes isolated from the stem wood of the South African tree Combretum Caffrum. Traditionally, the root bark of Combretum Caffrum was powdered and boiled and used by the Zulu tribe as a charm for harming an enemy, but there is no written evidence of use of the plant for treating cancer amongst the indigenous people of Africa. [5] A number of constituent stilbenes were found to inhibit the growth of cancer cells. Combretastatin A-4 (4, Figure 1 ) demonstrated potent antiproliferative activity against a number of human cancer cell lines including multi-drug resistant cancer cell lines [4] . Stilbene 4 binds to the colchicine domain of tubulin and induces vascular shutdown within tumours [6] . Clinically, a water-soluble prodrug, combretastatin A-4phosphate (CA4P, fosbretabulin, 5, Figure 1 ) is under evaluation in phase 3 trials for treatment of anaplastic thyroid cancer and in phase 2 trials for non-small cell lung cancer and platinum-resistant ovarian cancer [7] . In vivo, in isolated tumour systems, vascular shutdown is seen within 20 minutes of the start of infusion of 5. At 100 mg/kg, rapid and prolonged blood flow shutdown is evident, and both human and murine tumour models show extensive necrosis within 24 hours. These effects were also seen at doses between 25 and 1500 mg/kg, indicating the wide therapeutic window [6] . In addition to 5, a second structurally related prodrug (6, ombrabulin, Figure 1 , a water soluble serine amino acid prodrug) is in clinical trials [7, 8] . A related analogue from the combretastatin A series, combretastatin A-1 diphosphate (7, OXi4503, Figure 1 ), is being evaluated in hepatic and solid tumours as well as acute myeloid leukaemia [7] .
Many conformationally restricted analogues of 4 have been reported, the majority of which replace the isomerisable cis-double bond in 4 with a heterocycle. Reported heterocyclic CA-4 analogues include imidazole 8,[9] tetrazole 9 [10] and benzoxepin 10 [11] ( Figure 2 ). The azetidin-2-one (β-lactam) ring [12] is an alternative scaffold for potent non-isomerisable combretastatin analogues (11 -13, Figure 2 ) [13] [14] [15] [16] . Having previously investigated comprehensive structure-activity relationships of these series with a phenyl-substituted ring at the 3-position of the azetidinone ring, it was of importance to extend the SAR by investigating a range of aryl substituents at the 4-position. It was also valuable to further characterise the biochemical effects of both 4 and these β-lactam compounds. Herein we report novel findings for 4 and related β-lactam analogues in MCF-7 breast cancer cells.
Results and discussion
Chemistry
The design of this series of compounds incorporated a 3,4,5-trimethoxyphenyl ring at the N-1 position of the β-lactam ring, previously demonstrated to be the optimal substituent at this position [15] . This mimics the A-ring of 4 ( Figure 1 ). The choice of substituents at the 4-position was based on previously reported potent derivatives of 4. The first step in the synthesis of the required β-lactams was the formation of the imine precursors 14 -25. This is achieved by condensation of the appropriately substituted benzaldehydes and anilines (Scheme 1). The desired imines were obtained in high yields.
Synthesis of β-lactams 27 -33 and 35 -37 was carried out using the Staudinger reaction with in situ generation of a ketene and subsequent reaction with the appropriately substituted imine (Method I, Scheme 1 and Scheme 2). A modified Staudinger method (method II, Scheme 1) requiring overnight reaction was used to obtain bromo-containing β-lactam 34 as method I was unsuccessful [17] . Where the appropriate α-bromoacetate precursor was available, the Reformatsky reaction was used for azetidinone synthesis (26, Scheme 1, method III). The stereochemistry of the β-lactam product obtained can vary depending on numerous factors, including the reaction conditions, the order of addition of the reagents and the substituents present on both the imine and on the acid chloride [18] [19] [20] . The X-ray crystal β-Lactams 38, 39 and 40 are diphenyl substituted at the 4-position of the azetidinone ring. The imine precursors, obtained from the appropriately substituted benzophenones, could not be isolated under normal reflux conditions in ethanol. It has been noted previously that it is more difficult to synthesise Schiff bases from ketone precursors such as acetophenone and benzophenone than from less sterically hindered aldehydes such as para-methoxybenzaldehyde. Anhydrous conditions, lengthy reaction times, high temperatures and the use of activated molecular sieves are normally required [21] . A number of different reaction conditions were attempted for these compounds. Reaction of benzophenones with 3,4,5-trimethoxyaniline did not proceed when using 4Å molecular sieves, reflux conditions and anhydrous toluene [22] . Refluxing with benzene, molecular sieves and sodium bicarbonate also did not yield any of the desired imine [23] . An alternative, one-pot preparation of β-lactams using titanium (IV) chloride was explored [24] . This method uses half an equivalent of TiCl4 in the condensation of the appropriate aniline and benzophenone using tri-n-butylamine as the base. Subsequent reaction with the appropriate acid chloride without isolation of the intermediate imine yielded the desired β-lactams 38, 39 and 40 in low yields.
Pharmacology and Biochemical results
Antiproliferative activity in breast cancer cells
Compounds 26-40 were screened for their antiproliferative activity in the ER expressing MCF-7 human breast cancer cell line using the MTT assay [25] . The drug concentration required to inhibit the cell growth by 50% (IC50) was determined and the results are displayed in Table 1 . Additional screening using the ER independent MDA-MB-231 human breast cancer cell lines was carried out for selected analogues.
The antiproliferative activity of the 3-phenyl substituted β-lactams in MCF-7 and MDA-MB-231 breast cancer cells (Table 1 ) are in general agreement with our previously reported results obtained for a series of 3-unsubstituted -lactam compounds [14] . β-Lactam 13 was chosen as the lead compound due to both its synthetic accessibility and the potential to examine a number of related analogues to examine the structure-activity relationships of derivatives with variations at the 4-position of the β-lactam ring. 4-Ethoxy derivate 26 was the most potent compound in this series in MCF-7 cells with an IC50 value of 0.22 μM. This is a decrease in activity of approximately 10-fold compared to 13, and is consistent with previously reported ethoxy-substituted combretastatin derivatives [26] . Surprisingly 27, the 4-fluoro compound displays sub-micromolar activity which is not shown in a related 3-unsubstituted compound previously reported. [14] However, potent fluoro-containing analogues of 4 are known [27] . Ring B with a bromide substituent was reported to have moderate activity in a range of cell lines [28] . In our series, this compound was not as potent as either the lead compound 13 or 26. However, this compound has the potential to be used as an intermediate in the synthesis of further boronic acid βlactams, as has been reported for potent boronic acid bioisosteres of 4 [29] . The 2-naphthalene moiety has been demonstrated to be good surrogate for the B-ring of the combretastatin series [30] , and the value of 0.53 μM which was nearly 10-fold less potent than 13 ( Table 2 ).
The cytotoxicity of selected analogues at 10 µM was determined using an LDH assay. The range of cytotoxicity in MCF-7 cells was between 3% for 33 and 10.4% cell death for dimethylamino-containing analogue 28. These values are comparative to the percentage of cell death of 5.5% at 10 µM observed for 4 in MCF-7 cells. In MDA-MB-231 cells, cytotoxicity at 10 µM ranged from 0 % (analogues 27, 30, 31, 32 and 33) to 6.1 % (compound 29), again falling in the same low percentage range as 4 (4.3%). The cytotoxicity for the most potent compound, 26, was 5.4%. This confirms previous work in normal murine epithelial cells that both 4 and β-lactam derivatives are minimally cytotoxic to non-proliferating cells [15, 16] .
Tubulin polymerization and immunofluorescence
β-Lactam 26 was chosen for further study on the basis of its potent antiproliferative activity in MCF-7 cells, together with an assessment of its drug-like properties via a Tier 1 profiling screen. Compound 26
satisfies Lipinski's 'rule of five' for drug-like properties e.g. molecular weight (433) is less than 500, the number of oxygen/nitrogen atoms is less than 10, the number of hydrogen bond donors is less than 5 and the cLogP value of 3.72 (<5), imply that this is a moderately lipophilic-hydrophobic drug and is a suitable candidate for further investigation (in addition to predictions of permeability, metabolic stability, Pgp substrate status, blood-brain barrier partition, plasma protein binding and human intestinal absorption properties which indicated the suitability of these compounds for further development).
In this study, we investigated the tubulin-targeting properties of 26 by a turbidity assay and confocal microscopy. As expected, 26 (10 μM) completely inhibited the assembly of tubulin in a cell free tubulin turbidity assay in a similar manner to that previously reported for 4 ( Figure 4 ) thus confirming that the target of this series of compounds is tubulin. In an attempt to identify the cellular effects that may be relevant to the antiproliferative activity of 26, we evaluated their activity on the alteration of the microtubule network by tubulin immunostaining, comparing it to that of 4. Confocal analysis of MCF-7 cells stained with α-tubulin mAb demonstrated a well organised microtubular network in control cells ( Figure 5 ). Exposure to 4 (100 nM) or 26 (500 nM) for 16 h led to a complete loss of microtubule formation consistent with depolymerised microtubules ( Figure 5 ). Additionally, cells treated with 4 and 26 increased in cell size and contained multiple micronuclei -a phenomenon described as mitotic catastrophe. Mitotic catastrophe is a type of programmed cell death in response to DNA damage, characterised by giant multinucleated cells [31] . These findings are in agreement with previously published studies, where 5 induced mitotic catastrophe in chronic lymphocytic leukemia cells [32] .
Similarly, 4 and a combretastatin derivative induced mitotic catastrophe dependent on spindle checkpoint and caspase-3 activation in non-small cell lung cancer cells [33, 34] . Mitotic catastrophe has also been demonstrated for 4 and related derivatives in both human endothelial cells (HUVEC) and human lung carcinoma cells (H460) [35] . Taken together, these results confirm tubulin as the molecular target of this series of β-lactam combretastatin derivatives and demonstrate mitotic catastrophe in MCF-7 breast cancer cells for 4 and 26 for the first time.
Analysis of DNA content by flow cytometry.
We in untreated cells, P=0.02) together with a significant increase in apoptosis as determined by quantification of the sub-G1 population of cells (9.4% and 13.97% respectively compared to 1.65% in untreated cells) ( Table 3 and Figure 6 ).
Structural studies of β-lactam compound 26 in the colchicine-binding site of tubulin
The proposed mode of binding of β-lactam 26 was investigated by virtual molecular docking using a published crystal structure of DAMA-colchicine (41) bound to the colchicine domain of αβ-tubulin [36] . Crosslinking studies with trimethoxy substituted A-rings with more reactive groups have previously shown the importance of Cys241 in the binding process [36, 37] . A similar binding orientation is observed for the trimethoxyphenyl A-rings of 41 and 26 (Figure 7 ). The positioning of the trimethoxy substituents of the A-rings differ slightly due to the 3D conformation of the molecule but both can still interact favorably with Cys241 to provide the anchoring interaction in the binding site. These binding parallels may rationalize the antiproliferative potency observed for 26. The C-ring at the 3-position of the β-lactam is observed to fill the pocket of tubulin more optimally than in the case of colchicine. This binding orientation differs from that previously observed for a related series of β-lactams, where the aryl ring at the C4-position of the β-lactam filled the space occupied by the C-ring of colchicine [15, 16] .
Hydrogen bonding between sulfur and Ser178 is also depicted in 
Conclusion
Experimental Protocols
Chemistry
All reagents were commercially available and were used without further purification unless otherwise indicated. Toluene was dried by distillation from sodium and stored on activated molecular sieves (4 Å) and dichloromethane was dried by distillation from calcium hydride prior to use. IR spectra were recorded as thin films on NaCl plates or as KBr discs on a Perkin-Elmer Paragon 100 FT-IR spectrometer. 1 
General preparation of Schiff bases (14 -25)
A solution of the appropriately substituted aryl aldehyde (0.1 mol) and the appropriately substituted aryl amine (0.1 mol) in ethanol (50 mL) was heated at reflux for three hours. The reaction mixture was reduced to 25 mL under vacuum. The mixture was left to stand and the Schiff base product crystallized out of the solution. The crude product was then recrystallized from ethanol and filtered to yield the purified product. Schiff bases 15, 17, 19, 20 and 25 was prepared and isolated as previously reported [14] . 
General methods for preparation of 3-substituted azetidin-2-ones
Staudinger reaction (method I):
A solution consisting of acetyl chloride (7.5 mmol) in anhydrous CH2Cl2 (50 mL) was added dropwise to a stirring solution containing the appropriate imine (5 mmol) and triethylamine (15 mmol) in anhydrous CH2Cl2 (50 mL) at reflux in an inert atmosphere.
The solution was refluxed for 10 hours and then washed with saturated sodium bicarbonate solution (50 mL), dilute (10 %) HCl (50 mL) and brine (50 mL). The organic layer was dried and evaporated in vacuo.
Modified Staudinger reaction (method II):
The appropriate imine (10 mmol) and acetyl chloride (10 mmol) were added to anhydrous CH2Cl2 (50 mL) under nitrogen and the mixture was left stirring for 2 hours. Triethylamine (10 mmol) was injected dropwise and the mixture was stirred overnight. The mixture was washed with distilled water (50 mL) (twice) and then with saturated aqueous sodium bicarbonate solution (50 mL). The organic layer was dried by filtration through anhydrous sodium sulfate. The organic layer containing the product was collected and reduced in vacuo. 1-(3,4,5-trimethoxyphenyl) 
4-(4-Fluorophenyl)-3-phenyl-
Reformatsky microwave reaction (method III) for preparation of 4-(4-ethoxyphenyl)-3-
phenyl-1-(3,4,5-trimethoxyphenyl)azetidin-2-one 26. Zinc dust (6.9 mmol) was placed in 10 mL microwave vial and 5 mL of anhydrous benzene was added and the vial capped. TMCS (0.325 mL) was added. The reaction was stirred at 25°C, 50 W, for 15 mins and then heated at 100°C, 200W for 3 mins.
The vessel was allowed to cool before addition of N-(4-ethoxybenzylidene)-3,4,5-trimethoxyaniline 14 is used to extract the organic layer which is further washed with 20 mL 0.1 N HCl and 20 mL of water.
The organic layer is separated and dried using anhydrous sodium sulphate. 4-(4-Ethoxyphenyl)-3-phenyl- 
General method for synthesis of 4-diphenyl substituted β-lactams 38, 39 and 40
TiCl4 (2.0 mmol, 1M in CH2Cl2) was added to a solution of the appropriately substituted benzophenone for 20 min to ensure thorough colour diffusion before reading the absorbance. The absorbance value of control cells (no added compound) was set to 100 % cell viability and from this graphs of absorbance versus cell density per well were prepared to assess cell viability and from these, graphs of percentage cell viability versus concentration of subject compound added were drawn.
Cytotoxicity.
Cytotoxicity was determined using the CytoTox 96 non-radioactive cytotoxicity assay by Promega following the manufacturer's protocol [39] . The assay quantitatively measures lactate dehydrogenase (LDH) a stable cytosolic enzyme that is released upon cell lysis. Released LDH in culture supernatant is measured in a 30 minute coupled enzymatic assay, which results in the conversion of a tetrazolium salt (INT) into a red formazan product [40] .
MCF-7 and MDA-MB-231 cells were seeded in 96-well plates, incubated for 24 hours and then treated with compounds as described for the antiproliferative assay above. After 72 hours, 20 μL of lysis solution (10X) was added to the 'blank' wells and left for 1 hour to ensure 100 % death. 50 μL was removed from each well and transferred to a new 96-well plate. 50 μL of substrate mix from the LDH assay kit was added and the plate was incubated in the dark at room temperature for 30 minutes. After this period, 50 μL of stop solution was added to each well before reading the absorbance at a wavelength of 490 nm using a Dynatech MR5000 plate reader. Percentage cell death was calculated at 10 μM.
Tubulin polymerisation assay.
The effect of a selected analogue 26 on the polymerisation of purified bovine brain tubulin was determined spectrophotometrically by monitoring the change in turbidity. Lyophilised tubulin (Cytoskeleton, Denver, CO) was re-suspended in ice cold G-PEM buffer (80 mM PIPES pH 6.9, 0.5 mM MgCl2, 1 mM EGTA, 1 mM GTP, 10.2% (v/v) glycerol) and added to wells on a half volume 96 well plate containing the designated concentration of drug (10 µM) or vehicle.
Samples were mixed well and tubulin assembly was monitored at A340 nm at 30 sec intervals for 60 min at 37 o C in a Spectramax 340PC spectrophotometer (Molecular Devices).
collection was gated to exclude cell debris and cell aggregates. At least 10,000 cells were analysed per sample. All data were recorded and analysed using the CellQuest software (Becton Dickinson). Hydrogens are not shown for clarity. Coloured by atom: Green (colchicine carbon); Pink (β-lactam carbon); red (oxygen); blue (nitrogen). Residue numbers are those used by Ravelli et al [36] . 
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